Is SZLSF or ORCC a better dividend investment in 2026?

SZLSF currently yields 39215.69% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: SZLSF offers higher current income.

What is the dividend yield difference between SZLSF and ORCC?

SZLSF has a forward dividend yield of 39215.69% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 39205.90 percentage points.

Home › Compare › SZLSF vs ORCC

SZLSF vs ORCC: Dividend Comparison 2026

SZLSF yields 39215.69% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SZLSF wins by $4.252735580217355e+22M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SZLSF

● Live price

39215.69%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.252735580217355e+22M

Annual income

$42,315,093,309,418,040,000,000,000,000.00

Full SZLSF calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — SZLSF vs ORCC

📍 SZLSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SZLSF	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SZLSF + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SZLSF pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SZLSF

Annual income on $10K today (after 15% tax)

$3,333,333.33/yr

After 10yr DRIP, annual income (after tax)

$35,967,829,313,005,333,000,000,000,000.00/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, SZLSF beats the other by $35,967,829,313,005,333,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SZLSF + ORCC for your $10,000?

SZLSF: 50%ORCC: 50%

100% ORCC50/50100% SZLSF

Portfolio after 10yr

$2.1263677901086776e+22M

Annual income

$21,157,546,654,709,020,000,000,000,000.00/yr

Blended yield

99.50%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

SZLSF

No analyst data

Altman Z

-336.3

Piotroski

2/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SZLSF buys

ORCC buys

No recent congressional trades found for SZLSF or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSZLSFORCC

Forward yield	39215.69% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$4.252735580217355e+22M	$21.4K ✓
Annual income after 10y	$42,315,093,309,418,040,000,000,000,000.00 ✓	$1.04
Total dividends collected	$4.251340866571809e+22M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: SZLSF vs ORCC ($10,000, DRIP)

Year	SZLSF Portfolio	SZLSF Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$3,932,269	$3,921,568.63	$11,190	$489.61	+$3.92M → SZLSF
2	$1,445,390,825	$1,441,183,297.58	$12,229	$256.01	+$1445.38M → SZLSF
3	$496,629,048,205	$495,082,480,022.34	$13,216	$130.74	+$496629.03M → SZLSF
4	$159,510,701,964,776	$158,979,308,883,196.16	$14,207	$66.02	+$159510701.95M → SZLSF
5	$47,892,225,784,148,210	$47,721,549,333,045,900.00	$15,234	$33.17	+$47892225784.13M → SZLSF
6	$13,442,027,069,357,296,000	$13,390,782,387,768,257,000.00	$16,317	$16.62	+$13442027069357.28M → SZLSF
7	$3,526,928,149,355,307,700,000	$3,512,545,180,391,095,400,000.00	$17,468	$8.32	+$3526928149355307.50M → SZLSF
8	$865,104,634,553,737,800,000,000	$861,330,821,433,927,700,000,000.00	$18,695	$4.16	+$865104634553737856.00M → SZLSF
9	$198,376,161,453,751,100,000,000,000	$197,450,499,494,778,630,000,000,000.00	$20,006	$2.08	+$198376161453751107584.00M → SZLSF
10	$42,527,355,802,173,560,000,000,000,000	$42,315,093,309,418,040,000,000,000,000.00	$21,407	$1.04	+$4.252735580217355e+22M → SZLSF

SZLSF vs ORCC: Complete Analysis 2026

SZLSF — Stock

StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in the United States and Canada. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is Aristotle, a multi-cancer panel test for simultaneously screening for various cancers from a single sample of blood with high sensitivity and specificity for each cancer. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; COVID polymerase chain reaction testing and blood test analysis; Prostate Health Index, a screening test for prostate cancer; and BreastSentry, a test to determine a woman's risk for developing breast cancer. The company was founded in 1998 and is headquartered in Richmond Hill, Canada.

Full SZLSF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this SZLSF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SZLSF vs SCHD SZLSF vs JEPI SZLSF vs O SZLSF vs KO SZLSF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.